Call Options Transactions Made in Q3 2023 in Ambrx Biopharma Inc. (AMAM)
This table provides information about the institutional ownership of Ambrx Biopharma Inc. (AMAM) during Q3 2023. The information is specifically focused on institutions that hold call options of Ambrx Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Paradigm Biocapital Advisors LP
New York, NY |
BUY
|
CALL |
210KNew |
$1.95M - $3.48M
|
210K
$5.87M
|
|
|
Nov 14, 2023
Q3 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
99.1KNew |
$922K - $1.65M
|
99.1K
$2.77M
|
|
|
Nov 14, 2023
Q3 2023
|
Great Point Partners LLC
Greenwich, CT |
BUY
|
CALL |
97.7KNew |
$909K - $1.62M
|
97.7K
$2.74M
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
31.7K+ 112.41% |
$295K - $526K
|
59.9K
$1.68M
|
|
|
Nov 15, 2023
Q3 2023
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
25.9KNew |
$241K - $430K
|
25.9K
$725K
|
|
|
Oct 27, 2023
Q3 2023
|
Belvedere Trading LLC
|
BUY
|
CALL |
9.8K+ 49.75% |
$91.1K - $163K
|
29.5K
$826K
|
|
|
Nov 14, 2023
Q3 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
4.93KNew |
$45.9K - $81.9K
|
4.93K
$138K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-7.6K- 12.44% |
$70.7K - $126K
|
53.5K
$1.5M
|
|
|
Nov 07, 2023
Q3 2023
|
Cutler Group LP
|
SELL
|
CALL |
-17K- 65.13% |
$158K - $282K
|
9.1K
$255K
|